About Forest Neurotech

Forest Neurotech develops a minimally invasive ultrasonic whole-brain computer interface that measures and modulates brain-wide neural activity using advanced ultrasound transducers and miniaturized electronics. This technology addresses imbalances in neurological and psychiatric disorders by enabling personalized understanding and treatment of brain function.

```xml <problem> Neurological and psychiatric disorders stem from imbalances within brain-wide networks, yet current methods for measuring and modulating neural activity are often invasive or lack the necessary spatial resolution for personalized treatment. Existing neuroimaging techniques may not provide the real-time feedback needed to adapt therapeutics effectively. </problem> <solution> Forest Neurotech is developing a minimally invasive ultrasonic whole-brain computer interface designed to measure and modulate brain activity across the entire brain. The implant integrates advanced ultrasound transducers and miniaturized electronics onto a single microchip, enabling neuroimaging and modulation throughout the brain. This technology aims to provide personalized understanding and treatment of neurological and psychiatric disorders by continuously monitoring brain-wide function and adapting therapeutics accordingly. The system leverages Butterfly Network’s Ultrasound-on-Chip technology. </solution> <features> - Minimally-invasive implant for whole-brain neuroimaging and modulation. - Integrated ultrasound transducers and miniaturized electronics on a single microchip. - Real-time monitoring of brain-wide neural activity. - Personalized therapeutic adjustments based on continuous feedback. - Utilizes Butterfly Network’s Ultrasound-on-Chip technology. </features> <target_audience> The primary target audience includes individuals suffering from neurological and psychiatric disorders, as well as clinicians and researchers seeking advanced tools for understanding and treating brain function. </target_audience> ```

What does Forest Neurotech do?

Where is Forest Neurotech located?

Forest Neurotech is based in Los Angeles, United States.

When was Forest Neurotech founded?

Forest Neurotech was founded in 2023.

How much funding has Forest Neurotech raised?

Forest Neurotech has raised 14000000.

Who founded Forest Neurotech?

Forest Neurotech was founded by Mikhail Shapiro.

Mikhail Shapiro - Founder/Adviser

Location

Los Angeles, United States

Founded

2023

Funding

14000000

Employees

18 employees

Looking for specific startups?

Try our free semantic startup search

Forest Neurotech

Score: 100/100

AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

forestneurotech.org 2K+

Crunchbase

Founded 2023 – Los Angeles, United States

Funding

Estimated Funding

$14M+

Team (15+)

Mikhail Shapiro

Founder/Adviser

Company Description

Problem

Neurological and psychiatric disorders stem from imbalances within brain-wide networks, yet current methods for measuring and modulating neural activity are often invasive or lack the necessary spatial resolution for personalized treatment. Existing neuroimaging techniques may not provide the real-time feedback needed to adapt therapeutics effectively.

Solution

Forest Neurotech is developing a minimally invasive ultrasonic whole-brain computer interface designed to measure and modulate brain activity across the entire brain. The implant integrates advanced ultrasound transducers and miniaturized electronics onto a single microchip, enabling neuroimaging and modulation throughout the brain. This technology aims to provide personalized understanding and treatment of neurological and psychiatric disorders by continuously monitoring brain-wide function and adapting therapeutics accordingly. The system leverages Butterfly Network’s Ultrasound-on-Chip technology.

Features

Minimally-invasive implant for whole-brain neuroimaging and modulation.

Integrated ultrasound transducers and miniaturized electronics on a single microchip.

Real-time monitoring of brain-wide neural activity.

Personalized therapeutic adjustments based on continuous feedback.

Utilizes Butterfly Network’s Ultrasound-on-Chip technology.

Target Audience

The primary target audience includes individuals suffering from neurological and psychiatric disorders, as well as clinicians and researchers seeking advanced tools for understanding and treating brain function.